Dementia expert says evidence behind Biogen Alzheimer’s drug ‘wasn’t sufficient’ for FDA approval

Visits: 8

“Desperation should drive funding for Alzheimer’s research, it should not drive the interpretation of scientific evidence,” Karlawish said. Read More Go To Source